myelodysplastic syndrome

Showing NaN - NaN of 26

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • +6 more
  • Birmingham, Alabama
  • +297 more
Jan 28, 2023

Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +190 more
Jan 30, 2023

Collection of Tissue Samples for Cancer Research

Recruiting
  • Neoplasms
  • +3 more
  • Biopsy
  • Atlanta, Georgia
  • +9 more
Jan 23, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Biospecimen Collection
  • +3 more
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

Completed
  • Myelodysplastic Syndrome
  • +13 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Azacitidine, Sargramostim)

Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 23, 2022

Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or

Terminated
  • Myelodysplastic Syndrome
  • +3 more
  • La Jolla, California
  • +157 more
Sep 22, 2022

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Completed
  • Acute Myeloid Leukemia
  • +19 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Lewes, Delaware
  • +16 more
Aug 3, 2022

Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • FT-2102 (olutasidenib)
  • +2 more
  • Los Angeles, California
  • +59 more
Mar 2, 2022

Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)

Active, not recruiting
  • Anemia
  • +3 more
  • Epoetin Alfa
  • +2 more
  • Birmingham, Alabama
  • +512 more
Mar 1, 2022

Leukemia, Lymphoma, Blood Cancer Trial in Baltimore (Bone Marrow Transplant (BMT))

Recruiting
  • Leukemia
  • +5 more
  • Bone Marrow Transplant (BMT)
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022

Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • cytogenetic analysis
  • La Jolla, California
  • +136 more
Aug 16, 2021

Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)

Completed
  • Myelodysplastic Syndrome
  • Iron Overload
  • Birmingham, Alabama
  • +47 more
Jul 21, 2021

Myelodysplastic Syndrome, MDS Trial in Canada, United States (ASTX727 Dose Escalation, ASTX727 Dose Confirmation, ASTX727

Completed
  • Myelodysplastic Syndrome
  • MDS
  • ASTX727 Dose Escalation
  • +2 more
  • Phoenix, Arizona
  • +16 more
Dec 1, 2020

Multi-center, Survival Data Collection in Subjects Previously

Completed
  • Myelodysplastic Syndrome
    • Scottsdale, Arizona
    • +14 more
    Nov 6, 2019

    Myelodysplastic Syndrome Trial in Worldwide (MEDI4736 Evaluate MEDI4736 in MDS, VIDAZA, tremelimumab)

    Completed
    • Myelodysplastic Syndrome
    • MEDI4736 Evaluate MEDI4736 in MDS
    • +2 more
    • Scottsdale, Arizona
    • +20 more
    May 9, 2019

    Myelodysplastic Syndrome Trial in Baltimore (Lenalidomide 50 mg, Lenalidomide 15 mg)

    Terminated
    • Myelodysplastic Syndrome
    • Lenalidomide 50 mg
    • Lenalidomide 15 mg
    • Baltimore, Maryland
      The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Sep 21, 2018

    Myelodysplastic Syndrome Trial in United States (pracinostat, Placebo, Azacitidine)

    Completed
    • Myelodysplastic Syndrome
    • Mobile, Alabama
    • +23 more
    Sep 11, 2018

    Lymphoma, Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Fludarabine, Busulfan, Cyclophosphamide)

    Terminated
    • Lymphoma
    • +2 more
    • Baltimore, Maryland
      The Sydney Kimmel Comprehensive Cancer Center
    Jun 29, 2018

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome

    Completed
    • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    • +5 more
    • Ipilimumab
    • Laboratory Biomarker Analysis
    • New Haven, Connecticut
    • +8 more
    Mar 20, 2018

    Myelodysplastic Syndrome Trial in Worldwide (eltrombopag olamine, Placebo)

    Completed
    • Myelodysplastic Syndrome
    • eltrombopag olamine
    • Placebo
    • Birmingham, Alabama
    • +64 more
    Nov 8, 2017

    Lymphoma, Multiple Myeloma, Leukemia Trial in Baltimore, Houston, Seattle (Busulfan, Fludarabine, Cytoxan)

    Completed
    • Lymphoma
    • +3 more
    • Busulfan, Fludarabine, Cytoxan
    • Baltimore, Maryland
    • +2 more
    Jan 29, 2015